Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer

Junya Fukuoka, Takeshi Fujii, Joanna H. Shih, Tatiana Dracheva, Daoud Meerzaman, Audrey Player, Kyeong Hong, Sharon Settnek, Ajay Gupta, Kenneth Buetow, Stephen Hewitt, William D. Travis, Jin Jen

Research output: Contribution to journalArticle

158 Citations (Scopus)

Abstract

We immunohistochemically examined 12 core proteins involved in the chromatin remodeling machinery using a tissue microarray composed of 150 lung adenocarcinoma (AD) and 150 squamous cell carcinoma (SCC) cases. Most of the proteins showed nuclear staining, whereas some also showed cytoplasmic or membranous staining. When the expression patterns of all tested antigens were considered, proteins with nuclear staining clustered into two major groups. Nuclear signals of BRM, Ini-1, retinoblastoma, mSin3A, HDAC1, and HAT1 clustered together, whereas nuclear signals of BRG1, BAF155, HDAC2, BAF170, and RbAP48 formed a second cluster. Additionally, two thirds of the cases on the lung tissue array had follow-up information, and survival analysis was performed for each of the tested proteins. Positive nuclear BRM (N-BRM) staining correlated with a favorable prognosis in SCC and AD patients with a 5 year-survival of 53.5% compared with 32.3% for those whose tumors were negative for N-BRM (P = 0.015). Furthermore, patients whose tumors stained positive for both N-BRM and nuclear BRG1 had a 5 year-survival of 72% compared with 33.6% (P = 0.013) for those whose tumors were positive for either or negative for both markers. In contrast, membranous BRM (M-BRM) staining correlated with a poorer prognosis in AD patients with a 5 year-survival of 16.7% compared with those without MBRM staining (38.1%; P = 0.016). These results support the notion that BRM and BRG1 participate in two distinct chromosome remodeling complexes that are functionally complementary and that the nuclear presence of BRM, its coexpression with nuclear BRG1, and the altered cellular localization of BRM (M-BRM) are useful markers for nonsmall cell lung cancer prognosis.

Original languageEnglish (US)
Pages (from-to)4314-4324
Number of pages11
JournalClinical Cancer Research
Volume10
Issue number13
DOIs
StatePublished - Jul 1 2004
Externally publishedYes

Fingerprint

Chromatin Assembly and Disassembly
Non-Small Cell Lung Carcinoma
Staining and Labeling
Nuclear Proteins
Survival
Squamous Cell Carcinoma
Adenocarcinoma
Neoplasms
Retinoblastoma
Survival Analysis
Proteins
Chromosomes
Antigens
Lung

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Fukuoka, J., Fujii, T., Shih, J. H., Dracheva, T., Meerzaman, D., Player, A., ... Jen, J. (2004). Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. Clinical Cancer Research, 10(13), 4314-4324. https://doi.org/10.1158/1078-0432.CCR-03-0489

Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. / Fukuoka, Junya; Fujii, Takeshi; Shih, Joanna H.; Dracheva, Tatiana; Meerzaman, Daoud; Player, Audrey; Hong, Kyeong; Settnek, Sharon; Gupta, Ajay; Buetow, Kenneth; Hewitt, Stephen; Travis, William D.; Jen, Jin.

In: Clinical Cancer Research, Vol. 10, No. 13, 01.07.2004, p. 4314-4324.

Research output: Contribution to journalArticle

Fukuoka, J, Fujii, T, Shih, JH, Dracheva, T, Meerzaman, D, Player, A, Hong, K, Settnek, S, Gupta, A, Buetow, K, Hewitt, S, Travis, WD & Jen, J 2004, 'Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer', Clinical Cancer Research, vol. 10, no. 13, pp. 4314-4324. https://doi.org/10.1158/1078-0432.CCR-03-0489
Fukuoka, Junya ; Fujii, Takeshi ; Shih, Joanna H. ; Dracheva, Tatiana ; Meerzaman, Daoud ; Player, Audrey ; Hong, Kyeong ; Settnek, Sharon ; Gupta, Ajay ; Buetow, Kenneth ; Hewitt, Stephen ; Travis, William D. ; Jen, Jin. / Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. In: Clinical Cancer Research. 2004 ; Vol. 10, No. 13. pp. 4314-4324.
@article{e590e54ce45d496e87a575bad4095c62,
title = "Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer",
abstract = "We immunohistochemically examined 12 core proteins involved in the chromatin remodeling machinery using a tissue microarray composed of 150 lung adenocarcinoma (AD) and 150 squamous cell carcinoma (SCC) cases. Most of the proteins showed nuclear staining, whereas some also showed cytoplasmic or membranous staining. When the expression patterns of all tested antigens were considered, proteins with nuclear staining clustered into two major groups. Nuclear signals of BRM, Ini-1, retinoblastoma, mSin3A, HDAC1, and HAT1 clustered together, whereas nuclear signals of BRG1, BAF155, HDAC2, BAF170, and RbAP48 formed a second cluster. Additionally, two thirds of the cases on the lung tissue array had follow-up information, and survival analysis was performed for each of the tested proteins. Positive nuclear BRM (N-BRM) staining correlated with a favorable prognosis in SCC and AD patients with a 5 year-survival of 53.5{\%} compared with 32.3{\%} for those whose tumors were negative for N-BRM (P = 0.015). Furthermore, patients whose tumors stained positive for both N-BRM and nuclear BRG1 had a 5 year-survival of 72{\%} compared with 33.6{\%} (P = 0.013) for those whose tumors were positive for either or negative for both markers. In contrast, membranous BRM (M-BRM) staining correlated with a poorer prognosis in AD patients with a 5 year-survival of 16.7{\%} compared with those without MBRM staining (38.1{\%}; P = 0.016). These results support the notion that BRM and BRG1 participate in two distinct chromosome remodeling complexes that are functionally complementary and that the nuclear presence of BRM, its coexpression with nuclear BRG1, and the altered cellular localization of BRM (M-BRM) are useful markers for nonsmall cell lung cancer prognosis.",
author = "Junya Fukuoka and Takeshi Fujii and Shih, {Joanna H.} and Tatiana Dracheva and Daoud Meerzaman and Audrey Player and Kyeong Hong and Sharon Settnek and Ajay Gupta and Kenneth Buetow and Stephen Hewitt and Travis, {William D.} and Jin Jen",
year = "2004",
month = "7",
day = "1",
doi = "10.1158/1078-0432.CCR-03-0489",
language = "English (US)",
volume = "10",
pages = "4314--4324",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "13",

}

TY - JOUR

T1 - Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer

AU - Fukuoka, Junya

AU - Fujii, Takeshi

AU - Shih, Joanna H.

AU - Dracheva, Tatiana

AU - Meerzaman, Daoud

AU - Player, Audrey

AU - Hong, Kyeong

AU - Settnek, Sharon

AU - Gupta, Ajay

AU - Buetow, Kenneth

AU - Hewitt, Stephen

AU - Travis, William D.

AU - Jen, Jin

PY - 2004/7/1

Y1 - 2004/7/1

N2 - We immunohistochemically examined 12 core proteins involved in the chromatin remodeling machinery using a tissue microarray composed of 150 lung adenocarcinoma (AD) and 150 squamous cell carcinoma (SCC) cases. Most of the proteins showed nuclear staining, whereas some also showed cytoplasmic or membranous staining. When the expression patterns of all tested antigens were considered, proteins with nuclear staining clustered into two major groups. Nuclear signals of BRM, Ini-1, retinoblastoma, mSin3A, HDAC1, and HAT1 clustered together, whereas nuclear signals of BRG1, BAF155, HDAC2, BAF170, and RbAP48 formed a second cluster. Additionally, two thirds of the cases on the lung tissue array had follow-up information, and survival analysis was performed for each of the tested proteins. Positive nuclear BRM (N-BRM) staining correlated with a favorable prognosis in SCC and AD patients with a 5 year-survival of 53.5% compared with 32.3% for those whose tumors were negative for N-BRM (P = 0.015). Furthermore, patients whose tumors stained positive for both N-BRM and nuclear BRG1 had a 5 year-survival of 72% compared with 33.6% (P = 0.013) for those whose tumors were positive for either or negative for both markers. In contrast, membranous BRM (M-BRM) staining correlated with a poorer prognosis in AD patients with a 5 year-survival of 16.7% compared with those without MBRM staining (38.1%; P = 0.016). These results support the notion that BRM and BRG1 participate in two distinct chromosome remodeling complexes that are functionally complementary and that the nuclear presence of BRM, its coexpression with nuclear BRG1, and the altered cellular localization of BRM (M-BRM) are useful markers for nonsmall cell lung cancer prognosis.

AB - We immunohistochemically examined 12 core proteins involved in the chromatin remodeling machinery using a tissue microarray composed of 150 lung adenocarcinoma (AD) and 150 squamous cell carcinoma (SCC) cases. Most of the proteins showed nuclear staining, whereas some also showed cytoplasmic or membranous staining. When the expression patterns of all tested antigens were considered, proteins with nuclear staining clustered into two major groups. Nuclear signals of BRM, Ini-1, retinoblastoma, mSin3A, HDAC1, and HAT1 clustered together, whereas nuclear signals of BRG1, BAF155, HDAC2, BAF170, and RbAP48 formed a second cluster. Additionally, two thirds of the cases on the lung tissue array had follow-up information, and survival analysis was performed for each of the tested proteins. Positive nuclear BRM (N-BRM) staining correlated with a favorable prognosis in SCC and AD patients with a 5 year-survival of 53.5% compared with 32.3% for those whose tumors were negative for N-BRM (P = 0.015). Furthermore, patients whose tumors stained positive for both N-BRM and nuclear BRG1 had a 5 year-survival of 72% compared with 33.6% (P = 0.013) for those whose tumors were positive for either or negative for both markers. In contrast, membranous BRM (M-BRM) staining correlated with a poorer prognosis in AD patients with a 5 year-survival of 16.7% compared with those without MBRM staining (38.1%; P = 0.016). These results support the notion that BRM and BRG1 participate in two distinct chromosome remodeling complexes that are functionally complementary and that the nuclear presence of BRM, its coexpression with nuclear BRG1, and the altered cellular localization of BRM (M-BRM) are useful markers for nonsmall cell lung cancer prognosis.

UR - http://www.scopus.com/inward/record.url?scp=3042851775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042851775&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-03-0489

DO - 10.1158/1078-0432.CCR-03-0489

M3 - Article

VL - 10

SP - 4314

EP - 4324

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 13

ER -